NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 61 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,027,027 | $15,386,000 | 1.26% |
| Sio Capital Management, LLC | 304,376 | $2,310,000 | 0.46% |
| GSA CAPITAL PARTNERS LLP | 96,586 | $733,000 | 0.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $1,139,000 | 0.11% |
| Frontier Wealth Management LLC | 145,000 | $1,101,000 | 0.10% |
| Oak Grove Capital LLC | 19,975 | $152,000 | 0.07% |
| FNY Investment Advisers, LLC | 15,000 | $113,000 | 0.05% |
| PREMIER ASSET MANAGEMENT LLC | 12,977 | $98,000 | 0.02% |
| PILLAR PACIFIC CAPITAL MANAGEMENT LLC | 19,800 | $150,000 | 0.01% |
| Heritage Wealth Advisors | 11,000 | $83,490,000 | 0.01% |